Visacor

Maa: Uusi-Seelanti

Kieli: englanti

Lähde: Medsafe (Medicines Safety Authority)

Aktiivinen ainesosa:

Rosuvastatin calcium 20.8mg equivalent to 20 mg rosuvastatin;  

Saatavilla:

AstraZeneca Limited

INN (Kansainvälinen yleisnimi):

Rosuvastatin calcium 20.8 mg (= 20 mg rosuvastatin)

Annos:

20 mg

Lääkemuoto:

Film coated tablet

Koostumus:

Active: Rosuvastatin calcium 20.8mg equivalent to 20 mg rosuvastatin   Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Kpl paketissa:

Blister pack, Al/Al foil, 30 tablets

luokka:

Prescription

Prescription tyyppi:

Prescription

Valmistaja:

AstraZeneca UK Ltd

Käyttöaiheet:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Tuoteyhteenveto:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Valtuutus päivämäärä:

2009-07-31